Table 2 Comparison between children and adolescents with T1DM and controls regarding various clinico-laboratory parameters.
| Â | Â | Children and adolescents with T1DM | Control | Â | Â |
|---|---|---|---|---|---|
| Â | Â | (n=46) | (n=46) | Test | p value |
Gender | Male | 21 (45.7%) | 18 (39.1%) | X2=0.41 | 0.520 |
| Â | Female | 25 (54.3%) | 28 (60.9%) | Â | Â |
Age (years) | Mean ± SD | 13.7±3.1 | 12.9±2.9 | t=0.98 | 0.260 |
|  | Range | 8–18 | 7–18 |  |  |
Clinical: | Â | Â | Â | Â | Â |
MDQ-10 | Deficiency | 13 (28.3%) | 0 (0.0%) | X2=15.1 | <0.001* |
Tingling | Positive | 10 (21.7%) | 0 (0.0%) | X2=11.2 | <0.001* |
Muscle cramps | Positive | 12 (26.1%) | 0 (0.0%) | X2=13.8 | <0.001* |
Laboratory: | Â | Â | Â | Â | Â |
Magnesium (mg/dL) | Mean ± SD | 1.3 ±0.1 | 2.0 ±0.2 1.7-2.4 | t=20.8 | <0.001* |
| Â | Range | 0.6-1.5 | Â | Â | Â |
PT (seconds) | Mean ± SD | 11.1 ±0.2 | 12.3 ±0.3 12-13 | t=21.6 | <0.001* |
|  | Range | 7–11.5 |  |  |  |
APTT (seconds) | Mean ± SD | 21.2 ±1.9 | 31.1 ±2.7 25-35 | t=17.6 | <0.001* |
|  | Range | 15–24 |  |  |  |
PAI-I (ng/ml) | Mean ± SD | 10.3 ±4.9 | 2.8 ±1.3 1.5-10.5 | t=9.95 | <0.001* |
|  | Range | 3.7–24 |  |  |  |
Cholesterol (mg/dl) | Mean ± SD | 173.0 ±41.6 | 101.9 ±10.7 85.0-123.0 | t=11.23 | <0.001* |
|  | Range | 122.0–270.0 |  |  |  |
Triglycerides (mg/dl) | Mean ± SD | 92.1 ±33.8 | 66.4 ±18.3 40.0-91.0 | t=4.53 | <0.001* |
|  | Range | 40.0–166.0 |  |  |  |
HDL (mg/dl) | Mean ± SD | 55.3 ±14.9 | 67.4 ±8.11 | t=-4.81 | <0.001* |
|  | Range | 31.0–87.0 | 54.0-84.0 |  |  |
LDL-c (mg/dl) | Mean ± SD | 100.9 ±23.1 | 81.5 ±14.1 | t=4.84 | <0.001* |
| Â | Range | 60.0-160.0 | 65.0-110.0 | Â | Â |